Rituximab · ATC L01 · Oncology & immunology · Antineoplastic medicines
| # | Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|---|
| 1 | Mabthera | Roche Pakistan Ltd | 1400 mg/11.7 mL (120 mg/mL) | Solution for subcutaneous injection | 1's | 094764 | PKR 185,708.682026-07-29 | PKR 185,708.68/ vial/unit |
| 2 | Mabthera | Roche Pakistan Ltd | 1600 mg/13.4 mL (120 mg/mL) | Solution for subcutaneous injection | 1's | 094765 | PKR 211,032.592026-07-29 | PKR 211,032.59/ vial/unit |
| 3 | Ristova | Roche Pakistan Ltd | 100 mg/10 mL | Injection | 2's | 031394 | PKR 71,255.762026-07-29 | PKR 35,627.88/ vial/unit |
| 4 | Ristova | Roche Pakistan Ltd | 500 mg | Injection | 1's | 031395 | PKR 176,590.372026-07-29 | PKR 176,590.37/ vial/unit |
| 5 | Ristova | Roche Pakistan Ltd | 500 mg/50 mL | Injection | 1's | 031395 | PKR 176,590.372026-07-29 | PKR 176,590.37/ vial/unit |
| 6 | Tuximab | The Searle Company Limited | 100 mg/10 mL | Injection | 1's | 107882 | PKR 33,464.992026-07-23 | PKR 33,464.99/ vial/unit |
| 7 | Tuximab | The Searle Company Limited | 100 mg/10 mL | Injection | 2's | 107882 | PKR 65,591.402026-07-23 | PKR 32,795.70/ vial/unit |
| 8 | Tuximab | The Searle Company Limited | 500 mg/50 mL | Injection | 1's | 105572 | PKR 116,196.572026-07-23 | PKR 116,196.57/ vial/unit |
| 9 | Zytux | CCL Pharmaceuticals (Pvt.) Limited | 100 mg | Injection | 2's | 107898 | PKR 50,699.722026-07-23 | PKR 25,349.86/ vial/unit |
| 10 | Zytux | CCL Pharmaceuticals (Pvt.) Limited | 100 mg/10 mL | Injection | 1's | 107898 | PKR 25,867.202026-07-23 | PKR 25,867.20/ vial/unit |
Live record: https://medinfobase.com/generic/rituximab/